Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study

Clinical Practice ◽

Retrospective Study ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Nonsteroidal Aromatase Inhibitors

PR86 RETROSPECTIVE STUDY OF EVEROLIMUS WITH FULVESTRANT IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE METASTATIC BREAST CANCER PRETREATED WITH AROMATASE INHIBITORS(AI'S) AND SELECTIVE ESTROGEN MODIFIERS

The Breast ◽

10.1016/s0960-9776(15)30098-9 ◽

2015 ◽

Vol 24 ◽

pp. S51

Author(s):

Leen Vanacker

Keyword(s):

Breast Cancer ◽

Retrospective Study ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Hormone Receptor ◽

Metastatic Breast ◽

Hormone Receptor Positive

A Randomised Trial of Sequential Aromatase Inhibitors (AI) in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer. The SAINT Trial

http://isrctn.org/> ◽

10.1186/isrctn99515843 ◽

2012 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Randomised Trial ◽

Locally Advanced ◽

Treatment after Progression on Fulvestrant among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study

Scientific Reports ◽

10.1038/s41598-018-37472-z ◽

2019 ◽

Vol 9 (1) ◽

Cited By ~ 1

Author(s):

Yizhao Xie ◽

Yannan Zhao ◽

Chengcheng Gong ◽

Zhanhong Chen ◽

Yinbin Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Retrospective Study ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients

Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors

Journal of Breast Cancer ◽

10.4048/jbc.2013.16.1.66 ◽

2013 ◽

Vol 16 (1) ◽

pp. 66 ◽

Cited By ~ 4

Author(s):

June Koo Lee ◽

Seock-Ah Im ◽

Daewon Lee ◽

Ji-Yeon Kim ◽

Yoojoo Lim ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Korean Patients ◽

Nonsteroidal Aromatase Inhibitors

Survival analysis of sequential use of first-line tamoxifen versus aromatase inhibitors for estrogen-positive metastatic breast cancer in postmenopausal women

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.1093 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 1093-1093 ◽

Cited By ~ 1

Author(s):

V. Kyritsis ◽

M. de Lemos ◽

C. Speers ◽

J. Barnett

Keyword(s):

Breast Cancer ◽

Survival Analysis ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

First Line

Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer Patients

Cancer Investigation ◽

10.1080/07357900701224789 ◽

2007 ◽

Vol 25 (2) ◽

pp. 102-105 ◽

Cited By ~ 22

Author(s):

Paolo Carlini ◽

Andrea Michelotti ◽

Gianluigi Ferretti ◽

Sergio Ricci ◽

Diana Giannarelli ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Aromatase Inhibitors ◽

Clinical Evaluation ◽

Hormonal Therapy ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Nonsteroidal Aromatase Inhibitors

A review of the newer aromatase inhibitors in the management of metastatic breast cancer

Journal of Clinical Pharmacy and Therapeutics ◽

10.1046/j.1365-2710.1998.00145.x ◽

1998 ◽

Vol 23 (2) ◽

pp. 81-90 ◽

Cited By ~ 7

Author(s):

Reddy

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitors ◽

Screening of Clinical Practice in Management of Progression on Trastuzumab in metastatic breast cancer

Journal of Cancer Prevention & Current Research ◽

10.15406/jcpcr.2016.05.00147 ◽

2016 ◽

Vol 5 (1) ◽

Author(s):

Dina Hamza

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

531P The role of diuretics in treatment of aromatase inhibitors induced musculoskeletal symptoms in women with non metastatic breast cancer

Annals of Oncology ◽

10.1016/s0923-7534(21)00689-x ◽

2016 ◽

Vol 27 ◽

pp. ix172-ix173

Author(s):

A.M. Alhanafy ◽

A.A. Labeeb

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Musculoskeletal Symptoms

121P Impact of HER2 low (H2L) expression on prognosis in luminal locally advanced or metastatic breast cancer (BC): A retrospective study

Annals of Oncology ◽

10.1016/j.annonc.2021.03.135 ◽

2021 ◽

Vol 32 ◽

pp. S73

Author(s):

C. Saavedra Serrano ◽

B. Pérez Mies ◽

M. Gion Cortes ◽

A. Cortes Salgado ◽

M. Fernández Abad ◽

...

Keyword(s):

Breast Cancer ◽

Retrospective Study ◽

Locally Advanced ◽